CHELSEA HAMPTON: Open Payments
NPI 1598277386 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 16 payments from 8 companies in 2025. Trend: 2023 $293 · 2024 $300 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $68 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $64 |
| Ethicon US, LLC | 2 | $54 |
| AtriCure, Inc. | 2 | $45 |
| Getinge USA Sales, LLC | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 1 | $37 |
| Kestra Medical Technology Services, Inc. | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: LifeVest, VASOVIEW HEMOPRO 2, Echelon; Endopath, ATRICLIP LAA EXCLUSION SYSTEM, Assure WCD, STRATAFIX, AREXVY, SYNERGY ABLATION SYSTEM.
Industry payments across TX — which companies pay providers there.
